A community to share the outputs and insights of the EU Interreg Baltic Sea Region Project "BIC - Biomarker Commercialization" and its extension stage project "BIC BRIDGE".

Read more about the project: www.biomarker.nu

The Biomarker Challenge

Biomarkers’ discovery is an area becoming increasingly important in research and industry, giving rise to new areas of diagnostic and treatment, and could form the foundation for new innovative drivers for both researchers, enterprises, and SMEs.

According to “Biomarkers Market - Global Forecast to 2020” the global biomarkers market expects to reach a market share of $45.55 Billion by 2020 of which healthcare and R&D expenditure are the key growth drivers.

Nonetheless, the challenges for the market uptake of these innovations are significant, as the development and commercialization of biomarkers are time-consuming, difficult, and expensive.

Another challenge is to involve industry (pharmaceutical and diagnostic enterprises, SMEs, investors) much earlier in the development and commercialization process of biomarkers, while research institutions need guidance to select the most relevant biomarker discoveries and conduct a development plan that meets early requirements from a relevant industry partner.

BIC Tools

By enabling better and more efficient commercialization of biomarkers, the overall output of the BIC project will contribute to improving the realization and competitiveness of biomarker discovery with the Baltic Sea Region.

Therefore, BIC offers various tools:

• BIC MasterTool
• BIC Best Practice Handbook
• BIC TTO ReviewTool
• BIC Regulatory Guide

Funding

The project’s budget is EUR 2.55 million and is co-financed by the European Regional Development Fund through the Interreg Baltic Sea Region Programme with EUR 1.96 million.

....

From BIC to BIC BRIDGE

The development of the toolset continues...

BIC BRIDGE is based on the main outputs and results from the BiC – Biomarker Commercialization project. Thanks to the regular project, the BiC consortium managed to tackle specific challenges from the biomarker development and commercialization field.

BIC BRIDGE serves not only to improve the outputs delivered in the original project but also includes a whole new set of activities aiming at increasing the scope of the tools and broadening the target groups, as well as increasing usability, sustainability, and impact, through

• Commercialization and regulatory guidance in advanced stages of development
• Practical conversation of the Biomarker Commercialization Guide
• Educational Training Toolbox
• Increased visibility and awareness.